Companies: 10,795·Total market cap: $144.5T
ICU Medical, Inc.

ICU Medical, Inc.

ICUINASDAQHealthcare● Active
$137.48
+$0.87(+0.64%)
Market Cap$3.4B
P/E Ratio
52W High$160.29
52W Low$107
Overview

ICU Medical, Inc. (ICUI) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

icui · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
9
Hold
1
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 90.9%

12-Month Price Target

High

$165

Consensus

$164

+18.9% upside

Low

$163

Median: $164 · Last Close: $137.90

The ICU Medical, Inc. (ICUI) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month ICUI price target is $164.00, representing +18.9% upside from the current price of $137.90.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $164 (18.9%)

Consensus Target

$164.00

18.9% upside

High Target

$165

19.7%

Low Target

$163

18.2%

Current Price

$137.90

as of today

Based on analyst price targets, the ICUI stock price prediction for the next 12 months ranges from $163 to $165. The consensus ICUI price forecast of $164.00 implies 18.9% upside from the current price of $137.90.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$140.471.86%

1-day model range: $139.89–$141.05. Peak: $141.05 (+1.86%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$119-13.8%
2028$109-21.0%
2029$104-24.9%
2030$100-27.2%
2031-28.5%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)73.5Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ICUI · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$134.09BUY
MA 10$134.97BUY
MA 20$130.10BUY
MA 50$126.49BUY
MA 100$135.26BUY
MA 200$134.29BUY
Current $ICUI · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$135.45BUY
EMA 10$133.90BUY
EMA 20$131.30BUY
EMA 50$129.85BUY
EMA 100$132.02BUY
EMA 200$134.28BUY
Current $ICUI · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Needham2026-05-27
Upgrade ↑
HoldBuy
Keybanc2026-04-27
Maintains
OverweightOverweight
Piper Sandler2026-04-17
Maintains
OverweightOverweight
Keybanc2026-02-20
Maintains
OverweightOverweight
Piper Sandler2026-02-20
Maintains
OverweightOverweight
Piper Sandler2025-11-07
Maintains
OverweightOverweight
Keybanc2025-11-07
Maintains
OverweightOverweight
Keybanc2025-10-21
Maintains
OverweightOverweight
Piper Sandler2025-09-10
Maintains
OverweightOverweight
Raymond James2025-08-08
Maintains
Strong BuyStrong Buy

Wall Street analysts have recently issued updated ratings on ICU Medical, Inc. (ICUI) stock. Of the recent 70 rating actions, 9 were upgrades and 9 were downgrades. 11 analysts currently cover ICUI.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

ICUI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.2B

↓ 8.3% YoY

Revenue Next Year

$2.3B

↑ 4.4% YoY

EPS This Year

$8.17

EPS Next Year

$9.30

↑ 13.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ICUI EPS of $8.17 for the current fiscal year, based on estimates from 5 analysts. The ICUI revenue forecast is $2.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ICUI stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ICUI price target is $164.00 (+18.9% upside), with an analyst consensus of Buy.

The ICUI short-term stock prediction for tomorrow is $140.47 (+1.86%). The ICUI stock price prediction for 2027 estimates an average of $119. The ICUI stock prediction for 2030 projects a range of $96–$105.

ICU Medical, Inc. trades on NASDAQ under the ticker ICUI. The ICUI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 91% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ICUI forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month ICUI price target is $164.00, with a high forecast of $165.00 and a low of $163.00. The median price target is shown in the chart above when available. This implies +18.9% potential upside from the current price of $137.90.

ICUI price targetWhat is ICUI price targetICUI analyst price targetICUI 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.